Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Ropivacaine Mesylate market was valued at US$ 895.2 million in 2022 and is projected to reach US$ 1357.2 million by 2029, at a CAGR of 6.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
2 mg/mL (0.2%) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ropivacaine Mesylate include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP and Zhejiang Xianju Pharmaceutical Co.,Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup.
This report aims to provide a comprehensive presentation of the global market for Ropivacaine Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ropivacaine Mesylate. This report contains market size and forecasts of Ropivacaine Mesylate in global, including the following market information:
Global Ropivacaine Mesylate Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ropivacaine Mesylate Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ropivacaine Mesylate companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ropivacaine Mesylate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ropivacaine Mesylate Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Mesylate Market Segment Percentages, by Type, 2022 (%)
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Global Ropivacaine Mesylate Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Mesylate Market Segment Percentages, by Application, 2022 (%)
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
Global Ropivacaine Mesylate Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Mesylate Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ropivacaine Mesylate revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ropivacaine Mesylate revenues share in global market, 2022 (%)
Key companies Ropivacaine Mesylate sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ropivacaine Mesylate sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ropivacaine Mesylate, market overview.
Chapter 2: Global Ropivacaine Mesylate market size in revenue and volume.
Chapter 3: Detailed analysis of Ropivacaine Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ropivacaine Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ropivacaine Mesylate capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Ropivacaine Mesylate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ropivacaine Mesylate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ropivacaine Mesylate Overall Market Size
2.1 Global Ropivacaine Mesylate Market Size: 2022 VS 2029
2.2 Global Ropivacaine Mesylate Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ropivacaine Mesylate Sales: 2018-2029
3 Company Landscape
3.1 Top Ropivacaine Mesylate Players in Global Market
3.2 Top Global Ropivacaine Mesylate Companies Ranked by Revenue
3.3 Global Ropivacaine Mesylate Revenue by Companies
3.4 Global Ropivacaine Mesylate Sales by Companies
3.5 Global Ropivacaine Mesylate Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ropivacaine Mesylate Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ropivacaine Mesylate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ropivacaine Mesylate Players in Global Market
3.8.1 List of Global Tier 1 Ropivacaine Mesylate Companies
3.8.2 List of Global Tier 2 and Tier 3 Ropivacaine Mesylate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ropivacaine Mesylate Market Size Markets, 2022 & 2029
4.1.2 2 mg/mL (0.2%)
4.1.3 5 mg/mL (0.5%)
4.1.4 7.5 mg/mL (0.75%)
4.1.5 10 mg/mL (1%)
4.2 By Type - Global Ropivacaine Mesylate Revenue & Forecasts
4.2.1 By Type - Global Ropivacaine Mesylate Revenue, 2018-2023
4.2.2 By Type - Global Ropivacaine Mesylate Revenue, 2024-2029
4.2.3 By Type - Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
4.3 By Type - Global Ropivacaine Mesylate Sales & Forecasts
4.3.1 By Type - Global Ropivacaine Mesylate Sales, 2018-2023
4.3.2 By Type - Global Ropivacaine Mesylate Sales, 2024-2029
4.3.3 By Type - Global Ropivacaine Mesylate Sales Market Share, 2018-2029
4.4 By Type - Global Ropivacaine Mesylate Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ropivacaine Mesylate Market Size, 2022 & 2029
5.1.2 Surgical Anesthesia
5.1.3 Major Nerve Block
5.1.4 Acute Pain Management
5.1.5 Other
5.2 By Application - Global Ropivacaine Mesylate Revenue & Forecasts
5.2.1 By Application - Global Ropivacaine Mesylate Revenue, 2018-2023
5.2.2 By Application - Global Ropivacaine Mesylate Revenue, 2024-2029
5.2.3 By Application - Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
5.3 By Application - Global Ropivacaine Mesylate Sales & Forecasts
5.3.1 By Application - Global Ropivacaine Mesylate Sales, 2018-2023
5.3.2 By Application - Global Ropivacaine Mesylate Sales, 2024-2029
5.3.3 By Application - Global Ropivacaine Mesylate Sales Market Share, 2018-2029
5.4 By Application - Global Ropivacaine Mesylate Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Ropivacaine Mesylate Market Size, 2022 & 2029
6.2 By Region - Global Ropivacaine Mesylate Revenue & Forecasts
6.2.1 By Region - Global Ropivacaine Mesylate Revenue, 2018-2023
6.2.2 By Region - Global Ropivacaine Mesylate Revenue, 2024-2029
6.2.3 By Region - Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
6.3 By Region - Global Ropivacaine Mesylate Sales & Forecasts
6.3.1 By Region - Global Ropivacaine Mesylate Sales, 2018-2023
6.3.2 By Region - Global Ropivacaine Mesylate Sales, 2024-2029
6.3.3 By Region - Global Ropivacaine Mesylate Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Ropivacaine Mesylate Revenue, 2018-2029
6.4.2 By Country - North America Ropivacaine Mesylate Sales, 2018-2029
6.4.3 US Ropivacaine Mesylate Market Size, 2018-2029
6.4.4 Canada Ropivacaine Mesylate Market Size, 2018-2029
6.4.5 Mexico Ropivacaine Mesylate Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Ropivacaine Mesylate Revenue, 2018-2029
6.5.2 By Country - Europe Ropivacaine Mesylate Sales, 2018-2029
6.5.3 Germany Ropivacaine Mesylate Market Size, 2018-2029
6.5.4 France Ropivacaine Mesylate Market Size, 2018-2029
6.5.5 U.K. Ropivacaine Mesylate Market Size, 2018-2029
6.5.6 Italy Ropivacaine Mesylate Market Size, 2018-2029
6.5.7 Russia Ropivacaine Mesylate Market Size, 2018-2029
6.5.8 Nordic Countries Ropivacaine Mesylate Market Size, 2018-2029
6.5.9 Benelux Ropivacaine Mesylate Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Ropivacaine Mesylate Revenue, 2018-2029
6.6.2 By Region - Asia Ropivacaine Mesylate Sales, 2018-2029
6.6.3 China Ropivacaine Mesylate Market Size, 2018-2029
6.6.4 Japan Ropivacaine Mesylate Market Size, 2018-2029
6.6.5 South Korea Ropivacaine Mesylate Market Size, 2018-2029
6.6.6 Southeast Asia Ropivacaine Mesylate Market Size, 2018-2029
6.6.7 India Ropivacaine Mesylate Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Ropivacaine Mesylate Revenue, 2018-2029
6.7.2 By Country - South America Ropivacaine Mesylate Sales, 2018-2029
6.7.3 Brazil Ropivacaine Mesylate Market Size, 2018-2029
6.7.4 Argentina Ropivacaine Mesylate Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ropivacaine Mesylate Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Ropivacaine Mesylate Sales, 2018-2029
6.8.3 Turkey Ropivacaine Mesylate Market Size, 2018-2029
6.8.4 Israel Ropivacaine Mesylate Market Size, 2018-2029
6.8.5 Saudi Arabia Ropivacaine Mesylate Market Size, 2018-2029
6.8.6 UAE Ropivacaine Mesylate Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Ropivacaine Mesylate Major Product Offerings
7.1.4 Pfizer Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Akorn
7.2.1 Akorn Company Summary
7.2.2 Akorn Business Overview
7.2.3 Akorn Ropivacaine Mesylate Major Product Offerings
7.2.4 Akorn Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.2.5 Akorn Key News & Latest Developments
7.3 Anant Pharmaceuticals
7.3.1 Anant Pharmaceuticals Company Summary
7.3.2 Anant Pharmaceuticals Business Overview
7.3.3 Anant Pharmaceuticals Ropivacaine Mesylate Major Product Offerings
7.3.4 Anant Pharmaceuticals Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.3.5 Anant Pharmaceuticals Key News & Latest Developments
7.4 SGPharma
7.4.1 SGPharma Company Summary
7.4.2 SGPharma Business Overview
7.4.3 SGPharma Ropivacaine Mesylate Major Product Offerings
7.4.4 SGPharma Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.4.5 SGPharma Key News & Latest Developments
7.5 Nephron Pharmaceuticals
7.5.1 Nephron Pharmaceuticals Company Summary
7.5.2 Nephron Pharmaceuticals Business Overview
7.5.3 Nephron Pharmaceuticals Ropivacaine Mesylate Major Product Offerings
7.5.4 Nephron Pharmaceuticals Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.5.5 Nephron Pharmaceuticals Key News & Latest Developments
7.6 Sintetica SA
7.6.1 Sintetica SA Company Summary
7.6.2 Sintetica SA Business Overview
7.6.3 Sintetica SA Ropivacaine Mesylate Major Product Offerings
7.6.4 Sintetica SA Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.6.5 Sintetica SA Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Ropivacaine Mesylate Major Product Offerings
7.7.4 AstraZeneca Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Manus Aktteva Biopharma LLP
7.8.1 Manus Aktteva Biopharma LLP Company Summary
7.8.2 Manus Aktteva Biopharma LLP Business Overview
7.8.3 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Major Product Offerings
7.8.4 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.8.5 Manus Aktteva Biopharma LLP Key News & Latest Developments
7.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
7.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Summary
7.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
7.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Major Product Offerings
7.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Key News & Latest Developments
7.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
7.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Summary
7.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Business Overview
7.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Major Product Offerings
7.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.11 Yangzi River Pharmaceutical Group
7.11.1 Yangzi River Pharmaceutical Group Company Summary
7.11.2 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Business Overview
7.11.3 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Major Product Offerings
7.11.4 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.11.5 Yangzi River Pharmaceutical Group Key News & Latest Developments
7.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Summary
7.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Business Overview
7.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Major Product Offerings
7.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Key News & Latest Developments
7.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
7.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Summary
7.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Business Overview
7.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Major Product Offerings
7.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales and Revenue in Global (2018-2023)
7.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Key News & Latest Developments
8 Global Ropivacaine Mesylate Production Capacity, Analysis
8.1 Global Ropivacaine Mesylate Production Capacity, 2018-2029
8.2 Ropivacaine Mesylate Production Capacity of Key Manufacturers in Global Market
8.3 Global Ropivacaine Mesylate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ropivacaine Mesylate Supply Chain Analysis
10.1 Ropivacaine Mesylate Industry Value Chain
10.2 Ropivacaine Mesylate Upstream Market
10.3 Ropivacaine Mesylate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ropivacaine Mesylate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
